IL125164A - Process for preparing 2,4-dihydroxypyridine and 2,4-dihydroxy-3-nitropyridine - Google Patents

Process for preparing 2,4-dihydroxypyridine and 2,4-dihydroxy-3-nitropyridine

Info

Publication number
IL125164A
IL125164A IL12516496A IL12516496A IL125164A IL 125164 A IL125164 A IL 125164A IL 12516496 A IL12516496 A IL 12516496A IL 12516496 A IL12516496 A IL 12516496A IL 125164 A IL125164 A IL 125164A
Authority
IL
Israel
Prior art keywords
dihydroxypyridine
nitropyridine
dihydroxy
preparing
Prior art date
Application number
IL12516496A
Other languages
English (en)
Other versions
IL125164A0 (en
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of IL125164A0 publication Critical patent/IL125164A0/xx
Publication of IL125164A publication Critical patent/IL125164A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IL12516496A 1996-01-02 1996-12-23 Process for preparing 2,4-dihydroxypyridine and 2,4-dihydroxy-3-nitropyridine IL125164A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US949296P 1996-01-02 1996-01-02
PCT/US1996/020768 WO1997024327A1 (en) 1996-01-02 1996-12-23 Process for preparing 2,4-dihydroxypyridine and 2,4-dihydroxy-3-nitropyridine

Publications (2)

Publication Number Publication Date
IL125164A0 IL125164A0 (en) 1999-01-26
IL125164A true IL125164A (en) 2003-03-12

Family

ID=21737998

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12516496A IL125164A (en) 1996-01-02 1996-12-23 Process for preparing 2,4-dihydroxypyridine and 2,4-dihydroxy-3-nitropyridine

Country Status (21)

Country Link
US (2) US6307054B1 (de)
EP (1) EP0909270B1 (de)
JP (1) JP2000502709A (de)
KR (1) KR19990076966A (de)
AP (1) AP772A (de)
AT (1) ATE219767T1 (de)
AU (1) AU722894B2 (de)
BR (1) BR9612341A (de)
CA (1) CA2241887C (de)
CZ (1) CZ203998A3 (de)
DE (1) DE69622051T2 (de)
DK (1) DK0909270T3 (de)
EA (1) EA000884B1 (de)
ES (1) ES2178725T3 (de)
HU (1) HUP9900969A3 (de)
IL (1) IL125164A (de)
OA (1) OA10803A (de)
PT (1) PT909270E (de)
SI (1) SI9620137B (de)
SK (1) SK283625B6 (de)
WO (1) WO1997024327A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1383427A (zh) 1998-12-31 2002-12-04 阿温蒂斯药物公司 制备n6-取代的脱氮杂一腺苷衍生物的方法
US7018365B2 (en) 1999-05-21 2006-03-28 Micro Therapeutics, Inc. Threaded syringe with quick stop
US6784165B1 (en) * 1999-11-23 2004-08-31 Aderis Pharmaceuticals, Inc. Treatment of heart rhythm disturbances with N6-substituted-5′-(N-substituted) carboxamidoadenosines
US7291603B2 (en) * 2002-07-24 2007-11-06 Ptc Therapeutics, Inc. Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations
WO2004100964A1 (en) * 2003-04-24 2004-11-25 Aderis Pharmaceuticals, Inc. Method of treating atrial fibrillation or atrial flutter
US20050118262A1 (en) * 2003-09-17 2005-06-02 Jack Aurora Controlled release formulation
GT200500281A (es) * 2004-10-22 2006-04-24 Novartis Ag Compuestos organicos.
GB0500785D0 (en) * 2005-01-14 2005-02-23 Novartis Ag Organic compounds
GB0607950D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
GB0607948D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
GB0607944D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
HRP20120494T1 (hr) 2006-04-21 2012-08-31 Novartis Ag Derivati purina za uporabu kao agonista adenozin a2a receptora
GB0607953D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
EP1889846A1 (de) 2006-07-13 2008-02-20 Novartis AG Purinderivate als A2a Agonisten
EP1903044A1 (de) * 2006-09-14 2008-03-26 Novartis AG Adenosinderivate als Agonisten des A2A-Rezeptors
JP2010508835A (ja) * 2006-11-10 2010-03-25 ノバルティス アーゲー シクロペンテンジオールモノアセテート誘導体
JP2012516843A (ja) 2009-02-02 2012-07-26 インドコ レメディーズ リミテッド ニトロピリジン誘導体の調製方法
CN114349873B (zh) * 2021-04-12 2023-03-17 杭州安誉科技有限公司 用于多孔模块辅助控制装置的高强度风扇支架
CN115716802A (zh) * 2022-10-20 2023-02-28 山西永津集团有限公司 一种4-溴-2-氯烟腈的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3547935A (en) * 1967-08-07 1970-12-15 American Cyanamid Co Certain nitro-4-pyridinols,n-oxides thereof and derivatives thereof
GB1199699A (en) * 1968-01-08 1970-07-22 Glanzstoff Ag Process for the Production of Condensed Aromatic Bis-(2,4-Dihydroxypyridine) Derivatives
DE3308449A1 (de) * 1982-08-19 1984-03-15 Rütgerswerke AG, 6000 Frankfurt Verfahren zur reindarstellung von 2-chlor-6-alkoxy-3-nitropyridinen
JP3261190B2 (ja) * 1993-01-27 2002-02-25 広栄化学工業株式会社 2−ヒドロキシ−3,5−ジニトロピリジン類の製造法

Also Published As

Publication number Publication date
KR19990076966A (ko) 1999-10-25
OA10803A (en) 2003-01-28
JP2000502709A (ja) 2000-03-07
CA2241887C (en) 2004-02-24
AP772A (en) 1999-10-15
BR9612341A (pt) 1999-12-28
DK0909270T3 (da) 2002-10-07
DE69622051T2 (de) 2003-01-23
EP0909270A1 (de) 1999-04-21
HK1019590A1 (en) 2000-02-18
IL125164A0 (en) 1999-01-26
SK283625B6 (sk) 2003-10-07
CA2241887A1 (en) 1997-07-10
ATE219767T1 (de) 2002-07-15
ES2178725T3 (es) 2003-01-01
DE69622051D1 (de) 2002-08-01
EA000884B1 (ru) 2000-06-26
EP0909270A4 (de) 1999-04-21
CZ203998A3 (cs) 1999-11-17
US6392049B1 (en) 2002-05-21
EA199800621A1 (ru) 1999-02-25
WO1997024327A1 (en) 1997-07-10
HUP9900969A2 (hu) 1999-07-28
AU1354697A (en) 1997-07-28
PT909270E (pt) 2002-11-29
SI9620137A (sl) 1999-02-28
AU722894B2 (en) 2000-08-10
US6307054B1 (en) 2001-10-23
SI9620137B (sl) 2006-02-28
HUP9900969A3 (en) 2001-11-28
AP9801289A0 (en) 1998-09-30
EP0909270B1 (de) 2002-06-26
SK90698A3 (en) 2000-12-11

Similar Documents

Publication Publication Date Title
HU9702508D0 (en) Vitronectin-receptor-antagonists and process for producing them
IL125164A0 (en) Process for preparing 2,4-dihydroxypyridine and 2,4-dihydroxy-3-nitropyridine
EP0785205A4 (de) 2-silyloxy-tetrahydrothienopyridin, sein salz und verfahren zu seiner herstellung
HUP9902419A3 (en) Process for preparing nitrobiphenylene
HUP9800555A3 (en) 3,3-diphenylallylamine derivatives and process for their preparation
HUP0002105A3 (en) Method for preparing 1,1,1,3,3-pentachlorobutane
HU9702509D0 (en) Vitronectin-receptor-antagonists and process for producing them
ZA958161B (en) Process for preparing 1,3-alkanediols and 3-hydroxyaldehydes
HU9700595D0 (en) Fluoro-alkyl- and fluoro-alkoxy-substituted heterocyclic bradiquinine-antagonists, process for producing them and their use
IL129688A0 (en) Process for preparing substituted pyridines
HU9700566D0 (en) Amino-alkyl- and acyl-amino-alkyl-ethers, process for producing them and their use as bradiquinine-receptor-antagonists
ZA958160B (en) Process for preparing 1,3-alkanediols and 3-hydroxyaldehydes
IL126989A0 (en) Process for making 4,6-dihydroxypyrimidine
AU3255997A (en) Process for preparing 1,3-alkanediols
GB9602046D0 (en) Process
GB2317178B (en) Process for preparing 1-chloromethylsilatrane
EP0621866A4 (en) Process for preparing 3-acylestratrienes and acylbenzenes.
AU3744495A (en) Process for preparing 1,3-alkanediols and 3-hydroxyldehydes
SG53120A1 (en) Process for preparing 2-methylnaphthalene
EP0751111A3 (de) Verfahren zur Herstellung von 2,2-Dialkylaryliden-cycloalkanonen
AU1568895A (en) Process for preparing 2,6-dichloropyridine
AU3026697A (en) Process for preparing 4,6-diamino-resorcinol-dihydrochloride
EP0943689A4 (de) Verfahren zur herstellung von fr900482 und analoge verbindungen
HU9700628D0 (en) 4-thia-1-aza-bicyclo[3.2.0]heptan-3-imino-2-izopropiliden-7-oxo-beta-lactame derivatives, process for producing them and use of them
PL319673A1 (en) Biphenoles preparation process

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees